ABBOTT LABORATORIES — Director's Dealing 2013

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

OMB APPROVAL

Washington, D.C. 20549

Check this box if no

OMB Number: 3235-0287 December 31, Expires: 2014 Estimated average burden hours per 0.5 response

longer subject to Section

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

1. Form 4 or Form 5

obligations may continue. See Instruction 1(b).

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

1. Issuer Name and Ticker or Trading Symbol 5. Relationship of Reporting Person(s) to ABBOTT LABORATORIES [ABT] Issuer (Check all applicable) 3. Date of Earliest Transaction X Director 10% Owner (Month/Day/Year) Other 06/30/2013 Officer (give (specify title below) below)

1. Name and Address of Reporting Person[*]

Alpern Robert J

(Last) (First) (Middle) 333 CEDAR STREET, C203 SHM (Street) NEW HAVEN CT 06520 (City) (State) (Zip)

1. If Amendment, Date of Original Filed 6. Individual or Joint/Group Filing (Month/Day/Year) (Check Applicable Line) X Form filed by One Reporting Person Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned

1.Title 2. Transaction 2A. Deemed 3. 4. Securities 5. Amount of 6. 7. Nature of Date Execution Date, Transaction Acquired (A) or Securities Ownership of Indirect Security (Month/Day/Year) if any Code Disposed of (D) Beneficially Form: Beneficial (Instr. 3) (Month/Day/Year) (Instr. 8) (Instr. 3, 4 and 5) Owned Direct (D) Ownership Following or Indirect (Instr. 4) (A) Reported (I) or Transaction(s) (Instr. 4) Code V Amount (D) Price (Instr. 3 and 4)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned

( e.g. , puts, calls, warrants, options, convertible securities)

==> picture [510 x 133] intentionally omitted <==

----- Start of picture text -----

1. Title of 2. 3. Transaction 3A. Deemed 4. 5. 6. Date 7. Title and 8. Price of 9. Number of 10. 11. NatureDerivative Conversion Date Execution Date, Transaction Number of Exercisable and Amount of Derivative Derivative Ownership of IndirectSecurity or Exercise (Month/Day/Year) if any Code Derivative Expiration Date Underlying Security Securities Form of Beneficial(Instr. 3) Price of (Month/Day/Year) (Instr. 8) Securities (Month/Day/Year) Securities (Instr. 5) Beneficially Derivative OwnershipDerivative Acquired (Instr. 3 and 4) Owned Security: (Instr. 4)Security (A) or Following Direct (D)Disposed Reported or Indirectof (D) Transaction(s) (I)(Instr. 3, (Instr. 4) (Instr. 4)4, and 5)AmountorNumberDate Expiration ofCode V (A) (D) Exercisable Date Title SharesStockEquivalent $ 0 [(1)] 06/30/2013 A 225 [(1)] [(1)] Commonshares 225 $ 34.88 2,891 [(2)] DUnits----- End of picture text -----

Explanation of Responses:

1. Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. 2. Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

• If the form is filed by more than one reporting person, see Instruction 4(b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.